NATR - NATURES SUNSHINE PRODUCTS INC
24.76
-0.320 -1.292%
Share volume: 167,835
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$25.08
-0.32
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-07-2024 | 08-08-2024 | 11-07-2024 | 03-11-2025 | 05-06-2025 | 07-31-2025 | 11-06-2025 | |
| Assets | ||||||||
| Total Assets | 247.267 M | 235.831 M | 245.333 M | 240.855 M | 252.702 M | 254.875 M | 264.805 M | |
| Current Assets | 160.156 M | 152.036 M | 163.529 M | 160.579 M | 170.782 M | 171.838 M | 186.084 M | |
| Inventories | 62.653 M | 62.304 M | 62.298 M | 59.443 M | 64.928 M | 69.320 M | 67.335 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 77.773 M | 68.695 M | 78.704 M | 84.700 M | 86.486 M | 81.345 M | 95.554 M | |
| Total Non-current Assets | 802.000 K | 890.000 K | 892.000 K | 915.000 K | 937.000 K | 1.041 M | 1.107 M | |
| Property Plant Equipment | 45.271 M | 44.832 M | 41.994 M | 39.585 M | 37.701 M | 35.930 M | 33.972 M | |
| Other Assets | 41.840 M | 38.963 M | 39.810 M | 40.691 M | 44.219 M | 47.107 M | 44.749 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 247.267 M | 235.831 M | 245.333 M | 240.855 M | 252.702 M | 254.875 M | 264.805 M | |
| Total liabilities | 87.560 M | 79.431 M | 82.716 M | 79.864 M | 85.602 M | 91.193 M | 98.101 M | |
| Total current liabilities | 68.881 M | 63.649 M | 67.150 M | 65.692 M | 70.741 M | 75.854 M | 83.649 M | |
| Accounts Payable | 9.029 M | 8.422 M | 8.875 M | 8.912 M | 9.865 M | 9.924 M | 7.119 M | |
| Other liabilities | 13.631 M | 12.793 M | 12.677 M | 11.622 M | 12.137 M | 12.651 M | 11.826 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 2.107 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 13.631 M | 12.793 M | 12.677 M | 11.622 M | 12.137 M | 12.651 M | 11.826 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 154.056 M | 150.610 M | 156.528 M | 155.313 M | 161.285 M | 157.681 M | 160.502 M | |
| Common stock | 119.063 M | 114.014 M | 113.946 M | 114.577 M | 115.146 M | 104.662 M | 103.553 M | |
| Retained earnings | 52.032 M | 53.381 M | 57.728 M | 57.407 M | 62.154 M | 67.487 M | 72.821 M |